SEARCH

SEARCH BY CITATION

References

  • Adalbert R., Gilley J. and Coleman M. P. (2007) Aβ, tau and ApoE4 in Alzheimer’s disease: the axonal connection. Trends Mol. Med. 13, 135142.
  • Andre F., Schartz N. E., Movassagh M. et al. (2002) Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360, 295305.
  • Cataldo A. M., Barnett J. L., Pieroni C. and Nixon R. A. (1997) Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer’s disease: neuropathologic evidence for a mechanism of increased β-amyloidogenesis. J. Neurosci. 17, 61426151.
  • Cataldo A. M., Peterhoff C. M., Troncoso J. C., Gomez-Isla T., Hyman B. T. and Nixon R. A. (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157, 277286.
  • Cataldo A. M., Petanceska S., Terio N. B., Peterhoff C. M., Durham R., Mercken M., Mehta P. D., Buxbaum J., Haroutunian V. and Nixon R. A. (2004) Aβ localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol. Aging 25, 12631272.
  • Choo-Smith L. P. and Surewicz W. K. (1997) The interaction between Alzheimer amyloid β(1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402, 9598.
  • De Gassart A., Geminard C., Fevrier B., Raposo G. and Vidal M. (2003) Lipid raft-associated protein sorting in exosomes. Blood 102, 43364344.
  • De Lacalle S., Cooper J. D., Svendsen C. N., Dunnett S. B. and Sofroniew M. V. (1996) Reduced retrograde labelling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats. Neuroscience 75, 1927.
  • Di Virgilio F., Milani D., Leon A., Meldolesi J. and Pozzan T. (1987) Voltage-dependent activation and inactivation of calcium channels in PC12 cells. Correlation with neurotransmitter release. J. Biol. Chem. 262, 91899195.
  • Faure J., Lachenal G., Court M. et al. (2006) Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 31, 642648.
  • Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H. and Raposo G. (2004) Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. USA 101, 96839688.
  • Hayashi H., Kimura N., Yamaguchi H. et al. (2004) A seed for Alzheimer amyloid in the brain. J. Neurosci. 24, 48944902.
  • Hurtado-Lorenzo A., Skinner M., El Annan J. et al. (2006) V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat. Cell Biol. 8, 124136.
  • Kakio A., Nishimoto S. I., Yanagisawa K., Kozutsumi Y. and Matsuzaki K. (2001) Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276, 2498524990.
  • Kokubo H., Saido T. C., Iwata N., Helms J. B., Shinohara R. and Yamaguchi H. (2005) Part of membrane-bound Abeta exists in rafts within senile plaques in Tg2576 mouse brain. Neurobiol. Aging 26, 409418.
  • Matsuo H., Chevallier J., Mayran N. et al. (2004) Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 303, 531534.
  • Matsuzaki K. and Horikiri C. (1999) Interactions of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry 38, 41374142.
  • McLaurin J. and Chakrabartty A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J. Biol. Chem. 271, 2648226489.
  • Mizuno T., Nakata M., Naiki H., Michikawa M., Wang R., Haass C. and Yanagisawa K. (1999) Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture. J. Biol. Chem. 274, 1511015114.
  • Mobius W., Van Donselaar E., Ohno-Iwashita Y., Shimada Y., Heijnen H. F., Slot J. W. and Geuze H. J. (2003) Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic 4, 222231.
  • Moos T. (1995) Age-dependent uptake and retrograde axonal transport of exogenous albumin and transferrin in rat motor neurons. Brain Res. 672, 1423.
  • Naiki H. and Gejyo F. (1999) Kinetic analysis of amyloid fibril formation. Methods Enzymol. 309, 305318.
  • Niewiadomska G. and Baksalerska-Pazera M. (2003) Age-dependent changes in axonal transport and cellular distribution of Tau 1 in the rat basal forebrain neurons. Neuroreport 14, 17011706.
  • Niewiadomska G., Baksalerska-Pazera M. and Riedel G. (2005) Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats. Ann. NY Acad. Sci. 1048, 287295.
  • Nixon R. A. (2005) Endosome function and dysfunction in Alzheimer’s disease and other neurodegenerative diseases. Neurobiol. Aging 26, 373382.
  • Porto-Carreiro I., Fevrier B., Paquet S., Vilette D. and Raposo G. (2005) Prions and exosomes: from PrPc trafficking to PrPsc propagation. Blood Cells Mol. Dis. 35, 143148.
  • Raiborg C., Rusten T. E. and Stenmark H. (2003) Protein sorting into multivesicular endosomes. Curr. Opin. Cell Biol. 15, 446455.
  • Rajendran L., Honsho M., Zahn T. R., Keller P., Geiger K. D., Verkade P. and Simons K. (2006) Alzheimer’s disease β-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA 103, 1117211177.
  • Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C. and Desaymard C. (1997) Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell 8, 26312645.
  • Savina A., Furlan M., Vidal M. and Colombo M. I. (2003) Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J. Biol. Chem. 278, 2008320090.
  • Selkoe D. J. (1997) Alzheimer’s disease: genotypes, phenotypes, and treatments. Science 275, 630631.
  • Stokin G. B. and Goldstein L. S. (2006) Axonal transport and Alzheimer’s disease. Annu. Rev. Biochem. 75, 607627.
  • Stokin G. B., Lillo C., Falzone T. L. et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease. Science 307, 12821288.
  • Thery C., Zitvogel L. and Amigorena S. (2002a) Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569579.
  • Thery C., Duban L., Segura E., Veron P., Lantz O. and Amigorena S. (2002b) Indirect activation of naive CD4 +  T cells by dendritic cell-derived exosomes. Nat. Immunol. 3, 11561162.
  • Vella L. J., Sharples R. A., Lawson V. A., Masters C. L., Cappai R. and Hill A. F. (2007) Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J. Pathol. 211, 582590.
  • Vingtdeux V., Hamdane M., Loyens A. et al. (2007a) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem. 282, 1819718205.
  • Vingtdeux V., Hamdane M., Begard S., Loyens A., Delacourte A., Beauvillain J. C., Buee L., Marambaud P. and Sergeant N. (2007b) Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiol. Dis. 25, 686696.
  • Wakabayashi M., Okada T., Kozutsumi Y. and Matsuzaki K. (2005) GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes. Biochem. Biophys. Res. Commun. 328, 10191023.
  • Wubbolts R., Leckie R. S., Veenhuizen P. T., Schwarzmann G., Mobius W., Hoernschemeyer J., Slot J. W., Geuze H. J. and Stoorvogel W. (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278, 1096310972.
  • Yamamoto N., Igbabvoa U., Shimada Y., Ohno-Iwashita Y., Kobayashi M., Wood W. G., Fujita S. C. and Yanagisawa K. (2004) Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain. FEBS Lett. 569, 135139.
  • Yamamoto N., Yokoseki T., Shibata M., Yamaguchi H. and Yanagisawa K. (2005) Suppression of Abeta deposition in brain by peripheral administration of Fab fragments of anti-seed antibody. Biochem. Biophys. Res. Commun. 335, 4547.
  • Yamamoto N., Fukata Y., Fukata M. and Yanagisawa K. (2007) GM1-ganglioside-induced Aβassembly on synaptic membranes of cultured neurons. Biochim. Biophys. Acta 1768, 11281137.
  • Yanagisawa K., Odaka A., Suzuki N. and Ihara Y. (1995) GM1 ganglioside-bound amyloid β-protein (A β): a possible form of preamyloid in Alzheimer’s disease. Nat. Med. 1, 10621066.
  • Yanagisawa K., McLaurin J., Michikawa M., Chakrabartty A. and Ihara Y. (1997) Amyloid β-protein (A β) associated with lipid molecules: immunoreactivity distinct from that of soluble A β. FEBS Lett. 420, 4346.
  • Yanagisawa M., Ariga T. and Yu R. K. (2006) Fucosyl-GM1 expression and amyloid-β protein accumulation in PC12 cells. J. Neurosci. Res. 84, 13431349.
  • Yuyama K., Yamamoto N. and Yanagisawa K. (2006) Chloroquine-induced endocytic pathway abnormalities: Cellular model of GM1 ganglioside-induced Aβ fibrillogenesis in Alzheimer’s disease. FEBS Lett. 580, 69726976.